References

  1. World Health Organization, Global Malaria Programme. World malaria report 2017. 2017; p196.

  2. Amoran OE, Ariba AA, Iyaniwura CA. Determinants of intermittent preventive treatment of malaria during pregnancy (IPTp) utilization in a rural town in Western Nigeria. Reproductive health. 2012;9:12. PubMed | Google Scholar

  3. Moore KA, Fowkes FJI, Wiladphaingern J, Wai NS, Paw MK, Pimanpanarak M et al. Mediation of the effect of malaria in pregnancy on stillbirth and neonatal death in an area of low transmission: observational data analysis. BMC Medicine. 2017 Dec;15(1): 98. PubMed | Google Scholar

  4. Briand V, Le Hesran JY, Mayxay M, Newton PN, Bertin G, Houzé S et al. Prevalence of malaria in pregnancy in southern Laos: a cross-sectional survey. Malaria Journal. 2016 Dec;15(1):436. PubMed | Google Scholar

  5. Steketee R, Nahlen B, Parise M, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. The American Journal of Tropical Medicine and Hygiene. 2001 Jan 1;64(suppl1-2):28-35. PubMed | Google Scholar

  6. Tako EA, Zhou A, Lohoue J, Leke R, Taylor DW, Leke RFG. Risk factors for placental malaria and its effect on pregnancy outcome in Yaoundé, Cameroon.Mars 2005; 72(3):236-242. Google Scholar

  7. Rogerson SJ, Unger HW. Prevention and control of malaria in pregnancy:new threats, new opportunities. Expert Review of Anti-infective Therapy. 2017 Apr 3;15(4):361-75. PubMed | Google Scholar

  8. OMS 2014. Document d'orientation en matière de politiques de l'OMS Traitement préventif intermittent pour le paludisme lors de la grossesse à la sulfadoxine-pyériméthamine-TPIp-SP. 2017 May 26; Access 3 Jun 2019

  9. Ministère de la Santé du Bénin. Bulletin du système d'information de routine sur le paludisme (SIRP) au Bénin. janvier 2016.

  10. Zone Sanitaire Cotonou II-III. Annuaire des statistiques sanitaires 2015.2015; 48p.

  11. World Health Organization (WHO). Stratégie mondiale de lutte contre le paludisme 2016-2030. WHO. 2015; 39. Accessed on 3 Jun 2019

  12. Azizi SC, Chongwe G, Chipukuma H, Jacobs C, Zgambo J, Michelo C. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study. BMC Pregnancy and Childbirth. 2018 Dec;18(1):118. PubMed | Google Scholar

  13. Diarra SS, Konaté D, Diawara SI, Tall M, Diakité M, Doumbia S. Factors associated with intermittent preventive treatment of malaria during pregnancy in Mali. para. 2019 Apr;105(2):299-302. PubMed | Google Scholar

  14. Owusu-Boateng I, Anto F. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana. Malaria journa. 2017;16(1):323. PubMed | Google Scholar

  15. Likwela JL, d'Alessandro U, Lokwa BL, Sorongane EM, Gasana G, Kakoma JB et al. Effet du traitement préventif intermittent (TPI) de la femme enceinte à la sulfadoxine-pyriméthamine (SP) sur le poids de naissance des enfants dans un milieu à résistance élevée du Plasmodium falciparum à la SP à l'Est de la République Démocratique du Congo (RDC). Rwanda Medical Journal. 2010;68(4):10-5. Google Scholar

  16. Moleins I, Agnamey P, Badiane M, Totet A, Brasseur P. Paludisme et grossesse: impact du traitement préventif intermittent à base de sulfadoxine pyriméthamine sur le poids de naissance à la maternité d'Oussouye (Casamance, Sénégal). La Revue Sage-Femme. 2010 Ju;9(3):123-7. Google Scholar

  17. Guyatt HL, Snow RW. Impact of Malaria during Pregnancy on Low Birth Weight in Sub-Saharan Africa. Clinical Microbiology Reviews. 2004 Oct 1;17(4):760-9. PubMed | Google Scholar

  18. Bertin G, Briand V, Bonaventure D, Carrieu A, Massougbodji A, Cot M et al. Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin. Malaria journal. 2011;10:196. PubMed | Google Scholar

  19. World Health Organization. World malaria report 2018. 2018